School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

INCYTE CORP INCY

Healthcare · Biotechnology

$112.79last close 2026-10-09 · market cap $22.86B · delayed data

Trailing returns

1M-10.49%
3M-4.83%
6M+16.33%
1Y+33.09%
5Y+71.18%

Basis: Adjusted daily closes.

What it does

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Open INCY in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies